NAFLD in Belgium: the fatty liver of the modern era
Non-alcoholic fatty liver disease (NAFLD) affects 25–30% of Belgian adults, and its inflammatory form (NASH) affects 3–5%. NASH can progress to liver fibrosis, cirrhosis, and hepatocellular carcinoma. Causes: hyperinsulinemia (insulin resistance), hypercaloric/hyperlipid diet, dysfunctional microbiome. Pathological mechanism: hepatic de novo lipogenesis → triglyceride accumulation → mitochondrial oxidative stress → hepatocyte necrosis → inflammation → fibrosis.
Mechanisms of ginger on the liver
1. AMPK → SREBP-1c inhibition → less lipogenesis
SREBP-1c is the central transcription factor of hepatic de novo lipogenesis. AMPK, activated by ginger, phosphorylates and inhibits SREBP-1c → less expression of lipogenesis enzymes (FAS, ACC, SCD1) → less synthesized ginger triglycerides → reduction of liver fat. Same mechanism as metformin (antidiabetic used in NAFLD).
2. PPAR-α → accelerated β-oxidation
PPAR-α is the central regulator of β-oxidation of fatty acids in hepatic mitochondria. Ginger activates PPAR-α → induction of CPT1 (transport of fatty acids into the mitochondria) → accelerated burning of liver fat → reduced intrahepatic triglycerides.
3. NF-κB → hepatic anti-inflammation (NASH)
The transition NAFLD→NASH is mediated by NF-κB in Kupffer cells (liver macrophages): TNF-α, IL-6, MCP-1 → activation of stellate cells (HSC) → fibrogenesis activation. 6-gingerol inhibits NF-κB in Kupffer cells → less pro-fibrotic cytokines → slowed progression NASH→fibrosis.
4. Nrf2 → hepatocyte protection
Mitochondrial oxidative stress is the driver of NAFLD progression. Nrf2, activated by ginger, induces SOD, catalase, and glutathione peroxidase in hepatocytes → neutralization of mitochondrial ROS → less hepatocyte cell death.
Clinical results
| NAFLD marker | Before ginger | After 12 weeks | Reduction |
|---|---|---|---|
| Liver fat (MRI) | 100% | 77% | -23% |
| ALT (alanine aminotransferase) | ~65 IU/L | ~53 IU/L | -18% |
| AST | ~55 IU/L | ~46 IU/L | -16% |
| Insulin Resistance (ginger HOMA-IR) | ~4.2 | ~3.3 | -21% |
FAQ — Ginger and NAFLD/NASH
Interactions with metformin (treatment diabetes-management-clinical-evidence-2026">diabetes and NAFLD)?
Complementary effects (both activate AMPK). No negative interaction documented. Possible synergistic association for NAFLD associated with diabetes.
Can ginger reverse liver fibrosis?
Unlikely on its own. For mild to moderate fibrosis (F1–F2), progression can be slowed. For advanced fibrosis (F3–F4/cirrhosis), specialized hepatology is indispensable.
Effective also for alcoholic fatty liver disease?
Similar mechanisms (oxidative stress, hepatic NF-κB), so potentially useful, but stopping alcohol remains the absolute priority.
AMPK, PPAR-α, NF-κB, Nrf2 — proven multi-targeted action on NAFLD.
→ Order on inti-drink.com
Related articles
Further reading on related topics :
- Ginger & NASH / Fatty Liver: Fatty Liver, Inflammation and Liver Fibrosis
- Ginger and fatty liver (NAFLD/NASH): AMPK, SREBP-1c, liver fat and hepatocyte protection
- Ginger and NASH: Non-Alcoholic Fatty Liver Disease, Transaminases & Inflammation
- Fatty Liver (NAFLD) in Belgium: sugary drinks, fructose and ginger as a hepatoprotector
- Active Aging Belgium: AMPK, NAD+/Sirtuins, Senescence and Ginger
- Ginger and depression: MAO-A/B, BDNF/TrkB, HPA axis and neuroplasticity — INTI
- Ginger and Liver: Fatty Liver (NAFLD), Detoxification and Protection
- Ginger and chronic fatigue syndrome (CFS/ME): reducing neuro-immune inflammation and restoring energy